story of the week
No Apparent Association Between Malignancy and Topical Pimecrolimus Use
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Malignancy and Topical Use of Pimecrolimus
JAMA Dermatol 2015 Feb 18;[EPub Ahead of Print], DJ Margolis, K Abuabara, OJ Hoffstad, J Wan, D Raimondo, WB BilkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.